Memokath-028, 044 and 045 stents for urethral obstruction

Patient organisation comments

A representative of Prostate Cancer UK provided the following comments on the Memokath‑028 stent specifically.

Memokath‑028 could potentially improve urinary symptoms or avoid the need for long-term indwelling catheterisation. It can also be removed more easily than other stents.

Memokath‑028 is a more convenient alternative to self-catheterisation for benign prostatic enlargement, because men would be able to urinate normally rather than needing a catheter. Memokath‑028 may improve quality of life and could also reduce risk of urinary tract infections. Finally, using the stent would mean that men were less reliant on healthcare workers (for example, for catheter replacement) and could care for themselves better at home without the need for district nursing services.

Some men may choose to use Memokath‑028 as a less invasive option compared with surgery for benign prostatic enlargement.

The commentator was not aware of any safety alerts for the Memokath‑028, but noted that they would like to see more high-quality evidence, including quality-of-life data and long-term studies looking at complications.